Stockreport

Monte Rosa Therapeutics touts molecular glue pipeline, tees up GFORCE updates and Phase II plans [Yahoo! Finance]

Monte Rosa Therapeutics, Inc.  (GLUE) 
PDF Monte Rosa Therapeutics (NASDAQ:GLUE) highlighted progress across its molecular glue degrader pipeline during a presentation at the Barclays 28th Annual Global Healthca [Read more]